Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell-Reference-Cited by-同舟云学术

Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell

Published:2022 Issue: Volume: Page:253-265
ISSN:
Container-title:Blood Substitutes and Oxygen Biotherapeutics
language:
Short-container-title:

Author:

Mittal Nivesh,Rogers Stephen,Dougherty Shannon,Wang Qihong,Moitra Parikshit,Brummet Mary,Cornett Elyse M.,Kaye Alan D.,Shekoohi Sahar,Buehler Paul,Spinella Philip,Pan Dipanjan,Doctor Allan

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-95975-3_24

Reference120 articles.

1. Eichelbronner O, et al. Effects of FIO2 on hemodynamic responses and O2 transport during RSR13-induced reduction in P50. Am J Physiol. 1999;277:H290–8.

2. Grocott HP, et al. Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat ï editorial comment. Stroke. 1998;29:1650–5.

3. Kilgore KS, et al. RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass. Circulation. 1999;100:35111–356.

4. Miyake M, et al. The effect of RSR13, a synthetic allosteric modifier of hemoglobin, on brain tissue pO2 (measured by EPR oximetry) following severe hemorrhagic shock in rats. Adv Exp Med Biol. 2003;530:319–29.

5. Steffen RP, Liard JF, Gerber MJ, Hoffman SJ. Allosteric modification of hemoglobin by RSR13 as a therapeutic strategy. Adv Exp Med Biol. 2003;530:249–59.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomaterial-related hemoglobin-based oxygen carriers, with emphasis on liposome and nano-capsules, for biomedical applications: current status and future perspectives;Journal of Nanobiotechnology;2024-06-16

2. Artificial cells for in vivo biomedical applications through red blood cell biomimicry;Nature Communications;2024-03-20

3. Research of storable and ready-to-use artificial red blood cells (hemoglobin vesicles) for emergency medicine and other clinical applications;Frontiers in Medical Technology;2022-12-23